Warning Recalled Blood Pressure Drugs Because of Cancer Risk

According to the U.S. Food and Drug Administration, Aurobindo Pharma USA is voluntarily recalling a blood pressure medication due to a possible cancer risk (FDA).

The Manufacturer is recalling two of its Quinapril and Hydrochlorothiazide Tablets (FDA)

Due to worries that the pills may be tainted with Nitrosamine, the Manufacturer is recalling two of its Quinapril and Hydrochlorothiazide Tablets, which are used to treat Hypertension and decrease Blood Pressure’s patients.

Numerous Vegetables, Dairy products, and Cured or Grilled Meats are among the foods that naturally contain Nitrosamines. According to the FDA, Prolonged exposure to high amounts of Nitrosamines can raise the chance of developing Cancer.

According to the FDA, both lots of the recalled Blood Pressure Medication have an expiration date of January 2023. The pills are described as "Pink tinted, scored, round, Biconvex, film-coated tablets, Debossed with 'D' on the scored side and '19' on the other side."

According to the FDA, there have been no complaints of adverse events connected to the recalled tablets.

Before returning their prescription, patients should speak with their Doctor or Healthcare provider about whether to keep taking their Medication or whether to pursue an alternative course of treatment, according to the FDA.

The recalled Tablets contain a combination of two medications: Quinapril Hydrochloride, an ACE inhibitor (Lowers Blood Pressure by relaxing blood vessels), and Hydrochlorothiazide, a Diuretic (Lowers Fluid Retention) that Lowers Blood Pressure.

"I suffered a stroke that nearly killed me." The Fitness guy

Some patients might be able to convert to a treatment plan that consists of two different tablets, one for each of the drugs that are present in the recalled pills.

In the past, the FDA has discovered nitrosamines in medications used to treat diabetes, High Blood Pressure, Heartburn, and Acid Reflux. Angiotensin II receptor blockers (ARBs), Ranitidine, Nizatidine, and Metformin are a few of the medications from specific manufacturers that have been recalled due to Nitrosamine impurities.

Medicines may develop Nitrosamines as a result of chemical reactions occurring throughout the drug production process.

However, because many cancers can develop slowly over decades, it is difficult to estimate the precise risk. Previous study has connected exposure to high amounts of Nitrosamines to several distinct types of cancer, including Pancreatic and Gastrointestinal Tumours. Despite being classified by the World Health Organization as potential human carcinogens, nitrosamine impurities found in prescription drugs may not pose a significant Cancer risk.

Testimonial